New York State Department Of Health Approved Applied DNA For TR8 Pharmacogenomic Testing Service
Portfolio Pulse from Benzinga Newsdesk
The New York State Department of Health has approved Applied DNA Sciences for its TR8 Pharmacogenomic Testing Service, which is expected to enhance the company's service offerings in the healthcare sector.
June 13, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences has received approval from the New York State Department of Health for its TR8 Pharmacogenomic Testing Service. This approval is likely to enhance the company's service offerings in the healthcare sector.
The approval from the New York State Department of Health is a significant regulatory milestone for Applied DNA Sciences. It allows the company to expand its service offerings in the healthcare sector, which could lead to increased revenue and market presence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100